Lois Privor-Dumm | Director, Policy, Advocacy And Communications, IVAC
Johns Hopkins Bloomberg School of Public Health | United States

Lois Privor-Dumm, Director, Policy, Advocacy And Communications, IVAC, Johns Hopkins Bloomberg School of Public Health

Lois Privor-Dumm is the Director, Policy, Advocacy & Communications at the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health and Secretariat Director for the International Council on Adult Immunization (ICAI).  Ms. Privor-Dumm brings extensive experience in new vaccine introductions and has supported decision-making and accelerated implementation in various geographies across the globe.  She leads a team that works with global, regional and country-level immunization and health experts and specializes in helping translate scientific evidence into equitable and sustainable policy that addresses the local context. She works across sectors to demonstrate immunization’s contributions to shared goals.  Her policy work helps highlight drivers and barriers to vaccine policy and uptake to support country strategies that build political will and public support. She was a founding partner for World Pneumonia Day and led the Secretariat for the Global Coalition Against Child Pneumonia (now Stop Pneumonia).  Most recently, she has been working with the diverse group of experts on ICAI to describe and frame the contributions of adult immunization to broader health and development goals and develop a roadmap to build global and regional policies. Prior to joining Johns Hopkins, she worked nearly 18 years in the private sector, most notably launching the pneumococcal conjugate vaccine in the US and supporting introductions in Latin America and Europe.  Lois holds a Master of International Business Studies (IMBA) from the University of South Carolina/Université Catholique de Louvain, Belgium and a certificate in business communications from the Johns Hopkins Carey School of Business.


Oct 31st Day 3 @ 11:20

Adult Vaccines – What’s needed for a rapidly changing demographic?

Same data, different results: an archetype analysis of adult vaccine decision making and uptake in 34 countriesAdult Immunization Evidence & Policy: Issues for the next decadeIssues for implementation of adult immunization programsIntroducing the International Council on Adult ImmunizationPanel with all speakers: Accelerating progress – what do we do differently?
last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates